Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli–driven acute inflammation

While the treatment of inflammatory disorders is generally based on inhibiting factors that drive onset of inflammation, these therapies can compromise healing (NSAIDs) or dampen immunity against infections (biologics). In search of new antiinflammatories, efforts have focused on harnessing endogeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Motwani, Madhur P., Colas, Romain A., George, Marc J., Flint, Julia D., Dalli, Jesmond, Richard-Loendt, Angela, De Maeyer, Roel P.H., Serhan, Charles N., Gilroy, Derek W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926908/
https://www.ncbi.nlm.nih.gov/pubmed/29563331
http://dx.doi.org/10.1172/jci.insight.94463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926908/
https://www.ncbi.nlm.nih.gov/pubmed/29563331
http://dx.doi.org/10.1172/jci.insight.94463

Ejemplares similares